FDA 483 - Flextronics Electronics Technology (Suzhou) Co., Ltd. - November 05, 2018

The provided document is an excerpt from a generic FDA Form 483, which outlines the purpose and regulatory basis for issuing inspectional observations. It states that the form assists inspected firms in complying with regulations enforced by the Food and Drug Administration, pursuant to Section 704(b) of the Federal Food, Drug and Cosmetic Act (21 USC 374(b)). This section mandates that an inspecting officer report any conditions or practices observed that indicate a product may be adulterated or prepared, packed, or held under insanitary conditions. The document also includes FOIA release information (request 2018-10345, released 10/19/2020) and contact details for FDA/CDRH/OCE/DID. However, the provided text does not contain specific inspection findings, a company name, inspection dates, main violations, or any required actions from a particular inspection. It serves as a preamble to an actual FDA 483 report rather than the report itself.